Ocular Gene Therapy


Ocular gene therapy has made a rapid progress in the past few years. This method directly administered into the eye, targeting diseases caused by mutations in the gene RPE65. Mutations in ths gene can produce Retinitis Pigmentosa, a rare but potentially Blinding diseases.


  • Gene replacement
  • DNA Nanoparticle
  • RNA Interference
  • Ex vivo for Retinal Pigmentosa

Related Conference of Ocular Gene Therapy

January 12-13, 2026

26th Global Ophthalmologists Annual Meeting

London, UK
April 20-21, 2026

3rd International Conference on Ophthalmology

Barcelona, Spain
May 07-08, 2026

7th International Conference on Optometry

Paris, France
May 25-26, 2026

10th World Congress on Eye and Vision

Madrid, Spain

Ocular Gene Therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in